COPD and microalbuminuria: a 12-year follow-up study

Area of Science:

• Pulmonary Medicine
• Nephrology
• Cardiovascular Research

Background:

• Chronic obstructive pulmonary disease (COPD) is associated with increased morbidity and mortality, potentially linked to systemic inflammation.
• Microalbuminuria, indicating endothelial dysfunction, may serve as an inflammatory marker for systemic effects in COPD.

Purpose of the Study:

• To investigate the association between microalbuminuria and all-cause mortality in individuals diagnosed with COPD.
• To determine if microalbuminuria can serve as a prognostic tool for COPD patients.

Main Methods:

• A 12-year follow-up study of 3129 participants from the Nord-Trøndelag Health Study (HUNT).
• Baseline assessment included spirometry and analysis of albuminuria using urinary albumin/creatinine ratio (2.5–30.0 mg·mmol⁻¹).
• Hazard ratios for all-cause mortality were calculated based on the presence of microalbuminuria in COPD patients.

Main Results:

• Individuals with COPD and microalbuminuria exhibited a 1.54-fold increased hazard ratio for all-cause mortality (95% CI 1.16–2.04) compared to those without.
• This association remained significant even after excluding participants with baseline cardiovascular disease.
• A positive trend was observed between increasing COPD severity stages and microalbuminuria-associated mortality.

Conclusions:

• Microalbuminuria is significantly associated with increased all-cause mortality in individuals with COPD.
• Microalbuminuria may be a valuable biomarker for identifying COPD patients with a poorer prognosis.
• Further research could explore interventions targeting endothelial dysfunction to improve outcomes in COPD.